Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 28, 2020; 26(8): 818-827
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.818
Published online Feb 28, 2020. doi: 10.3748/wjg.v26.i8.818
Table 3 Toxicity occurring during neoadjuvant chemotherapy, n (%)
| Adverse event | Total | Grade 3/4 |
| Leukopenia/neutropenia | 9 (25.0) | 6 (16.7) |
| Nausea/vomiting | 6 (16.7) | 3 (8.3) |
| Thrombocytopenia | 2 (5.6) | 1 (2.8) |
| Diarrhea | 2 (5.6) | 0 |
| Hand-foot skin reaction | 1 (2.8) | 0 |
| Allergy | 1 (2.8) | 0 |
| Alopecia | 1 (2.8) | 0 |
| Liver dysfunction | 3 (8.3) | 0 |
- Citation: Li Y, Ma FH, Xue LY, Tian YT. Neoadjuvant chemotherapy vs upfront surgery for gastric signet ring cell carcinoma: A retrospective, propensity score-matched study. World J Gastroenterol 2020; 26(8): 818-827
- URL: https://www.wjgnet.com/1007-9327/full/v26/i8/818.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i8.818